CrushSCI.com
67.8Average days
56Median days
19Fastest days
141Longest days
1092025 publications

Paper Review Records

All Paper Review Records

5 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

19 days

Deep Intronic SVA_E Retrotransposition as a Novel Factor in Canavan Disease Pathogenesis

Authors
Melina Weiß; Mareike Selig; Johannes Friedrich; Anna Wierczeiko; Stefan Diederich; Helen Sigel; Janna Bredow; Florian S. Eichler; Amanda Nagy; Denise Seyler; Laura Holthöfer; Susanne Gerber; Susann Schweiger; Matthias Linke; Annette BleyShow moreShow less
Affiliations
1. Institute for Human Genetics, University Medical Center of the Johannes Gutenberg University Mainz, Germany; 2. University Medical Center Hamburg-Eppendorf, University Children’s Hospital, Hamburg, Germany; 3. Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA; 4. Leibniz Institute for Resilience Research, Mainz, Germany; 5. Institute of Molecular Biology (IMB), Mainz, Germany.Show moreShow less
Official full-text evidence DOI Publisher page
42 days

Adeno-Associated Virus Gene Therapy Development: Early Planning and Regulatory Considerations to Advance the Platform Vector Gene Therapy Program

Authors
Richa Madan Lomash; Jean Dehdashti; Oleg A. Shchelochkov; Randy J. Chandler; Lina Li; Irini Manoli; Jennifer L. Sloan; Pramod Terse; Xin Xu; Dimah Saade; Rodica Stan; PaVe-GT team AverionGilberto V.BalakrishnanKrishnaBurdenSteven J.CampbellEggertonChenCatherineChoiEun-YoungDriscollClaireOksanaDukhaninaFerrySusanFoleyA. ReghanHausermanJanelle GeistMangalampalliVenkataMendozaChristopherNduwumwamiAsveltOuryJulienPorterForbes D.PorteroDeannaPortillaLiliRooneyJachintaTambeMitaliToddJoshuaToneyLondonRyzinCarol VanVepaSuryWagnerErikWangAmyZouYaqun; Gilberto V. Averion; Krishna Balakrishnan; Steven J. Burden; Eggerton Campbell; Catherine Chen; Eun-Young Choi; Claire Driscoll; Dukhanina Oksana; Susan Ferry; A. Reghan Foley; Janelle Geist Hauserman; Venkata Mangalampalli; Christopher Mendoza; Asvelt Nduwumwami; Julien Oury; Forbes D. Porter; Deanna Portero; Lili Portilla; Jachinta Rooney; Mitali Tambe; Joshua Todd; London Toney; Carol Van Ryzin; Sury Vepa; Erik Wagner; Amy Wang; Yaqun Zou; Philip J. Brooks; Donald C. Lo; Carsten G. Bönnemann; Charles P. Venditti; Anne R. Pariser; Elizabeth A. OttingerShow moreShow less
Affiliations
1. Therapeutic Development Branch, Division of Preclinical Innovation, National Center for Advancing Translational Sciences (NCATS), NIH, Rockville, Maryland, USA; 2. Division of Rare Diseases Research and Innovation, NCATS, NIH, Rockville, Maryland, USA; 3. Organic Acid Research Section, Metabolic Medicine Branch, National Human Genome Research Institute (NHGRI), NIH, Bethesda, Maryland, USA; 4. Neuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke (NINDS), NIH, Bethesda, Maryland, USA.Show moreShow less
Official full-text evidence DOI Publisher page
81 days

Unconstrained Precision Mitochondrial Genome Editing with αDdCBEs

Authors
Santiago R. Castillo; Brandon W. Simone; Karl J. Clark; Patricia Devaux; Stephen C. EkkerShow moreShow less
Affiliations
1. Virology and Gene Therapy Graduate Program, Mayo Clinic, Rochester, Minnesota, USA; 2. Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota, USA; 3. Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota, USA; 4. Department of Pediatrics and Department of Molecular Biosciences, Dell Medical School, The University of Texas at Austin, Austin, Texas, USA.Show moreShow less
Official full-text evidence DOI Publisher page
56 days

Complement Activation by Adeno-Associated Virus-Neutralizing Antibody Complexes

Authors
Cara West; Joel D. Federspiel; Kara Rogers; Arpana Khatri; Sheila Rao-Dayton; Mireia Fernandez Ocana; Sean Lim; Aaron Michael D'Antona; Sandra Casinghino; Suryanarayan SomanathanShow moreShow less
Affiliations
1. Pfizer, Inc., Rare Disease Research Unit, Cambridge, Massachusetts, USA; 2. Pfizer, Inc., Drug Safety Research & Development, Andover, Massachusetts, USA; 3. Pfizer, Inc., Drug Safety Research & Development, Groton, Connecticut, USA; 4. Pfizer, Inc., Rare Disease Research Unit, Kit Creek, North Carolina, USA; 5. Pfizer, Inc., Biomedicine Design, Cambridge, Massachusetts, USA.Show moreShow less
Official full-text evidence DOI Publisher page
141 days

Assessment of Pre-Clinical Liver Models Based on Their Ability to Predict the Liver-Tropism of Adeno-Associated Virus Vectors

Authors
Adrian Westhaus; Marti Cabanes-Creus; Kimberley L. Dilworth; Erhua Zhu; David Salas Gómez; Renina G. Navarro; Anais K. Amaya; Suzanne Scott; Magdalena Kwiatek; Alexandra L. McCorkindale; Tara E. Hayman; Silke Frahm; Dany P. Perocheau; Bang Manh Tran; Elizabeth Vincan; Sharon L. Wong; Shafagh A. Waters; Georgina E. Riddiough; Marcos V. Perini; Laurence O.W. Wilson; Julien Baruteau; Sebastian Diecke; Gloria González-Aseguinolaza; Giorgia Santilli; Adrian J. Thrasher; Ian E. Alexander; Leszek LisowskiShow moreShow less
Affiliations
1. Translational Vectorology Research Unit, Children's Medical Research Institute, Faculty of Medicine and Health, The University of Sydney, Westmead, Australia; 2. Great Ormond Street Institute of Child Health, University College London, London, United Kingdom; 3. Gene Therapy Research Unit, Children's Medical Research Institute and Sydney Children's Hospitals Network, Faculty of Medicine and Health, The University of Sydney, Westmead, Australia; 4. Gene Therapy and Regulation of Gene Expression Department, IdiSNA, Instituto de Investigación Sanitaria de Navarra, Universidad de Navarra, CIMA, Pamplona, Spain; 5. Australian e-Health Research Centre, Commonwealth Scientific and Industrial Research Organisation, Sydney, Australia; 6. Military Institute of Hygiene and Epidemiology, The Biological Threats Identification and Countermeasure Centre, Puławy, Poland; 7. Inventia Life Science Pty Ltd., Sydney, Australia; 8. Stem Cell Technology Platform, Max Delbrück Centrum for Molecular Medicine, Berlin, Germany; 9. Genetics and Genomic Medicine Department, Great Ormond Street Institute of Child Health, University College London, London, United Kingdom; 10. Metabolic Medicine Department, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom; 11. National Institute of Health Research Great Ormond Street Hospital Biomedical Research Centre, London, United Kingdom; 12. Department of Infectious Diseases, Melbourne Medical School, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia; 13. Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia; 14. Curtin Medical School, Curtin University, Perth, Australia; 15. Molecular and Integrative Cystic Fibrosis (miCF) Research Centre, University of New South Wales and Sydney Children's Hospital, Sydney, Australia; 16. School of Biomedical Sciences, Faculty of Medicine, University of New South Wales, Sydney, Australia; 17. Department of Respiratory Medicine, Sydney Children's Hospital, Faculty of Medicine, University of New South Wales, Sydney, Australia; 18. Department of Surgery, Austin Health Precinct, The University of Melbourne, Austin Health, Heidelberg, Australia; 19. Applied BioSciences, Faculty of Science and Engineering, Macquarie University, Sydney, Australia; 20. Discipline of Child and Adolescent Health, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; 21. Vector and Genome Engineering Facility, Children's Medical Research Institute, Faculty of Medicine and Health, The University of Sydney, Westmead, Australia; 22. Laboratory of Molecular Oncology and Innovative Therapies, Military Institute of Medicine, Warszawa, Poland.Show moreShow less
Official full-text evidence DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review62 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at [email protected]

Enter your email address so we can reply. Your details will remain private.